What ketamine and TMS actually cost — and how to pay less for more

Most people arrive at this page after a specific moment: they found a treatment that finally sounds plausible — ketamine, TMS, maybe Spravato — and then hit the pricing page, or worse, the absence of one. A clinic that won't tell you what it costs until after a consultation is telling you something about itself. Listen.

This guide lays out what each option realistically costs in 2026, how insurance actually treats each one, the three mechanisms that can cut your out-of-pocket cost substantially (HSA/FSA, superbills, and prior authorization), and how to tell whether a higher price buys a better protocol or just better marketing. Nothing here is financial or medical advice — it's the briefing we'd want before writing the check.

The coverage landscape, honestly

One sentence of orientation saves hours: in neurowellness, insurance coverage follows FDA approval, not evidence quality. Spravato and TMS are FDA-approved for depression, so insurers cover them under specific conditions. IV ketamine has comparably strong evidence in treatment-resistant depression but is used off-label — the drug is decades old and generic, so no manufacturer ever paid for the approval trial — and insurers use that as grounds to decline.

The result is a strange inversion: the treatment with the fastest onset (IV ketamine) is usually cash-pay, while slower options are reimbursed. Understanding that landscape is the starting point for planning — and for the neural optimization frame: you are not buying sessions, you are funding a neuroplasticity protocol, and the question is how to fund it intelligently.

What each option actually costs

Ranges below reflect typical US market pricing in 2026. Major metros run higher; package pricing and financing can move the effective number either direction.

Ketamine and insurance: the workarounds

Since IV ketamine is off-label for depression, direct coverage is rare — but "cash-pay" is not the whole story. Three legitimate paths reduce the real cost:

Spravato instead of IV ketamine

Esketamine nasal spray is FDA-approved for treatment-resistant depression, so insurers cover it at REMS-certified clinics when you meet criteria — typically documented failure of two or more antidepressants. Patient costs vary enormously by plan, from manageable copays to significant coinsurance, so verify benefits before committing. The trade-off versus IV: more visits, a fixed dosing schedule, and a different experience profile.

Out-of-network superbills

If you have a PPO with out-of-network benefits, ask your ketamine clinic for a superbill — an itemized receipt with diagnosis and procedure codes — and submit it yourself. Reimbursement of 40–70% of the insurer's allowed amount after your out-of-network deductible is common. Call your insurer first and ask specifically about out-of-network mental health benefits; get a reference number for the call.

HSA / FSA funds

Ketamine prescribed and supervised by a licensed clinician is a medical expense under IRS rules, which makes it HSA- and FSA-eligible in almost all cases. Paying with pre-tax dollars is effectively a 20–35% discount depending on your bracket. Keep itemized receipts; a letter of medical necessity helps if your administrator asks.

TMS and insurance: the authorization game

TMS is the rare interventional treatment with mainstream reimbursement. Most major insurers cover it for major depressive disorder after documented inadequate response to at least two antidepressant trials. The catch is process: prior authorization, specific device and protocol restrictions, and documentation requirements.

This is where clinic quality shows. A serious TMS program runs authorizations daily, knows each insurer's criteria, and will tell you within days whether you qualify. A clinic that shrugs and quotes self-pay first either doesn't accept insurance or doesn't want the paperwork — both are informative. Self-pay courses run $6,000–$12,000; accelerated protocols cost more. For a full treatment breakdown see our complete TMS guide.

HSA, FSA and superbills: the pre-tax stack

The most underused lever in neurowellness finance is boring: pre-tax dollars. If you have access to an HSA or FSA, routing a $5,000 ketamine protocol through it saves roughly $1,000–$1,750 depending on your tax bracket. Combined with a superbill reimbursement on a PPO plan, an effective protocol cost can drop 40% or more below the sticker price.

Sticker price is a starting bid. Pre-tax dollars, superbills, and prior authorization are the three levers that move it — and none of them require negotiating.

Price vs. value: what you're actually buying

Ketamine is a generic drug that costs a clinic very little. The molecule is not the product — the protocol is. What separates a $450 infusion from a $750 one is rarely the dose; it's screening depth, clinician presence, monitoring, integration support, outcome tracking, and the setting your nervous system does its work in. Our integration guide explains why the work between sessions is where durable change consolidates.

That cuts both ways. The cheapest option is often a dose without a program. But the most expensive option sometimes just has better interior design. The NeuroEdge Provider Standard — transparent pricing, comprehensive screening, integration support, outcome tracking — exists precisely to make this distinction legible. Clinics meeting all seven criteria appear in our Centers of Excellence.

Seven questions to ask before you pay anything

Every provider in the NeuroEdge directory is scored against the full Provider Standard, including transparent pricing. Compare clinics near you, or browse our city-by-city cost guides for local market pricing.

Frequently asked questions

Sources and further reading

• IRS — Publication 502: medical and dental expenses (HSA/FSA eligibility)
• FDA — Spravato (esketamine) prescribing information
• CMS — transcranial magnetic stimulation coverage determinations
• Clinical TMS Society — insurance and practice guidance
• Kaiser Family Foundation — out-of-network reimbursement basics

This guide is educational, not medical or financial advice, and does not replace evaluation by a qualified clinician or guidance from your insurer or tax advisor. Prices reflect typical US market ranges in 2026 and vary by provider, protocol, and region; coverage policies vary by plan and change over time. If you are in crisis, contact the 988 Suicide & Crisis Lifeline (call or text 988 in the US).